Zelivire 500 mg Tablet
PDF Leaflet Revision Date: 14 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of herpes zoster and recurrent genital herpes.
Dosage (summary)
Herpes zoster: 1000 mg TID for 7 days; Recurrent genital herpes: 500 mg BID for 5 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; avoid breastfeeding.
Key Drug Interactions
- Cimetidine
- Probenecid
- Mycophenolate mofetil
Contraindications
- Hypersensitivity to valaciclovir or aciclovir
Common side effects
- Headaches
- Nausea
- Fatigue
- Dizziness
Counselling Points
- Ensure adequate hydration
- Monitor for skin reactions
- Use safer sex practices
Serious warnings
- Risk of DRESS
- Thrombotic thrombocytopenic purpura
- Neurological effects in renal impairment
Important Disclaimer
The Zelivire 500 mg Tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
